颅内消淤汤治疗慢性硬膜下血肿临床的的疗效观察.docVIP

颅内消淤汤治疗慢性硬膜下血肿临床的的疗效观察 　　【摘要】 目的 探讨颅内消淤汤治疗慢性硬膜下血肿的临床效果。方法 60例慢性硬膜下血肿患者随机分为对照组和观察组， 各30例。观察组在常规西医治疗的基础上加用颅内消淤汤；对照组采用单纯的西医治疗。观察比较两组患者的平均住院时间及血肿体积情况。结果 治疗后观察组平均住院时间（12.5±3.4）d、血肿体积（22.4±5.7）ml低于对照组治疗后的平均住院时间（18.9±2.0）d、血肿体积（56.4±9.7）ml， 差异有统计学意义（P0.05）；观察组的总有效率为90.00%， 显著高于对照组的60.00%， 差异有统计学意义（P0.05）。结论 颅内消淤汤治疗慢性硬膜下血肿能显著改善症状， 加快颅内血肿的吸收， 缩短平均住院时间， 提高患者生存质量， 值得推广应用。 　　【关键词】 颅内消淤汤；慢性硬膜下血肿 　　【Abstract】 Objective To investigate clinical effect by cerebral blood stasis decoction in the treatment of chronic subdural hematoma. Methods A total of 60 patients with chronic subdural hematoma were randomly divided into control group and observation group， with 30 cases in each group. The observation group received additional cerebral blood stasis decoction in addition to conventional Western medicine treatment， and the control group received Western medicine treatment alone. Average hospital stay time and hematoma volume were observed and compared between the two groups. Results After treatment， the observation group had average hospital stay time as （12.5±3.4） d and hematoma volume as （22.4±5.7） ml， which were lower than （18.9±2.0） d and （56.4±9.7） ml in the control group. Their difference had statistical significance （P0.05）. The observation group had much higher total effective rate as 90.00% than 60.00% of the control group， and the difference had statistical significance （P0.05）. Conclusion Cerebral blood stasis decoction in treating chronic subdural hematoma can remarkably improve symptoms， accelerate absorption of intracranial hematoma， shorten average hospital stay time， and improve life quality in patients. This method is worth promoting and applying. 　　【Key words】 Cerebral blood stasis decoction； Chronic subdural hematoma 　　慢性硬膜下血肿（CSDH）为老年人群的多发病， 其起病隐匿， 易误诊、漏诊。慢性硬膜下血肿发生率占颅内血肿的10%。血肿量多者需手术治疗， 但老年人往往存在心、肺基础疾病， 手术麻醉并发症高， 且术后恢复也比较慢， 效果不甚满意。颅内消淤汤在颅脑损伤中的治疗价值：①在一定程度上减轻颅脑外伤后血流动力学改变所致的继发性损伤， 加快颅内血肿的吸收[1]；②可促进神经功能的恢复；③能降低血黏度， 改善血液的浓黏凝聚状态， 促进神经功能的恢复。有研究曾予血府逐淤汤治疗围手术期慢性硬膜下血肿， 疗